AGE-RELATED PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE IN PATIENTS WITH OSTEOSARCOMA

被引:1
|
作者
WANG, YM [1 ]
SUTOW, WW [1 ]
ROMSDAHL, MM [1 ]
PEREZ, C [1 ]
机构
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT SURG,HOUSTON,TX 77030
来源
CANCER TREATMENT REPORTS | 1979年 / 63卷 / 03期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:405 / 410
页数:6
相关论文
共 50 条
  • [31] Perioperative chemotherapy with and without high-dose methotrexate in adult osteosarcoma
    Negrao, Marcelo Vailati
    da Silva Rocha, Lucila S.
    Girardi, Daniel da Motta
    Feher, Olavo
    ANTI-CANCER DRUGS, 2017, 28 (08) : 915 - 921
  • [32] Pharmacogenetic analysis of high-dose methotrexate treatment in paediatric osteosarcoma
    Hegyi, M.
    Csordas, K.
    Eipel, O.
    Csagoly, E.
    Erdelyi, D. J.
    Semsei, A. F.
    Kovacs, G. T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S353 - S353
  • [33] SARCOIDOSIS FOLLOWING ADJUVANT HIGH-DOSE METHOTREXATE THERAPY FOR OSTEOSARCOMA
    SYBERT, A
    BUTLER, TP
    ARCHIVES OF INTERNAL MEDICINE, 1978, 138 (03) : 488 - 489
  • [34] Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma
    Hegyi, Marta
    Arany, Adam
    Semsei, Agnes F.
    Csordas, Katalin
    Eipel, Oliver
    Gezsi, Andras
    Kutszegi, Nora
    Csoka, Monika
    Muller, Judit
    Erdelyi, Daniel J.
    Antal, Peter
    Szalai, Csaba
    Kovacs, Gabor T.
    ONCOTARGET, 2017, 8 (06) : 9388 - 9398
  • [35] Target concentration achievement for efficacy and safety of patients with osteosarcoma treated with high-dose methotrexate based on individual pharmacokinetics: A retrospective study
    Nagamine, Ayumu
    Araki, Takuya
    Yashima, Hideaki
    Kamimura, Akane
    Shiraishi, Takumi
    Yanagawa, Takashi
    Obayashi, Kyoko
    Yamamoto, Koujirou
    ONCOLOGY LETTERS, 2023, 25 (02)
  • [36] High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma - Incidence, treatment, and outcome
    Widemann, BC
    Balis, FM
    Kempf-Bielack, B
    Bielack, S
    Pratt, CB
    Ferrari, S
    Bacci, G
    Craft, AW
    Adamson, PC
    CANCER, 2004, 100 (10) : 2222 - 2232
  • [37] Ambulatory High-dose Methotrexate Administration in Pediatric Osteosarcoma Patients at a Single Institution in Argentina
    Rubio, Jose A. Villegas
    Cacciavillano, Walter
    Rose, Adriana
    Zubizarreta, Pedro
    Scopinaro, Marcelo
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2017, 39 (07) : E349 - E352
  • [38] AMBULATORY HIGH-DOSE METHOTREXATE ADMINISTRATION IN PEDIATRIC OSTEOSARCOMA PATIENTS AT A SINGLE INSTITUTION IN ARGENTINA
    Villegas Rubio, Jose Antonio
    Cacciavillano, Walter
    Rose, Adriana
    Sampor, Claudia
    Guitter, Myriam
    Alfaro, Elizabeth
    Zubizarreta, Pedro
    Scopinaro, Marcelo
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 777 - 778
  • [39] EXPERIENCE WITH PREOPERATIVE, HIGH-DOSE METHOTREXATE (HDMTX) CONTAINING CHEMOTHERAPY IN PATIENTS WITH OSTEOSARCOMA (OSA)
    HONEGGER, HP
    CSERHATI, MD
    VONHOCHSTETTER, A
    HOFMANN, V
    GROSCURTH, P
    CANCER DRUG DELIVERY, 1986, 3 (01): : 69 - 69
  • [40] SFOPOS94:: A randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients
    Le Deley, Marie-Cecile
    Guinebretiere, Jean-Marc
    Gentet, Jean-Claude
    Pacquement, Helene
    Pichon, Fabienne
    Marec-Berard, Perrine
    Entz-Werle, Natacha
    Schmitt, Claudine
    Brugieres, Laurence
    Vanel, Daniel
    Dupouy, Noelle
    Tabone, Marie-Dominique
    Kalifa, Chantal
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (04) : 752 - 761